Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wheeler

Showing results (931-940 of 1,217) with videos related to

Pageof 122
Sort By:
Annals of Internal Medicine|December 5, 2022
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKDMeir Schechter, Niels Jongs, Glenn M Chertow, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 1, 2023
Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of FrailtyPriya Vart, Jawad H Butt, Niels Jongs, et al.
Journal of Neurodevelopmental Disorders|August 7, 2014
Associated features in females with an FMR1 premutationAnne C Wheeler, Donald B Bailey, Elizabeth Berry-Kravis, et al.
Kidney International|February 5, 2015
Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conferenceMarkus Ketteler, Grahame J Elder, Pieter Evenepoel, et al.
Clinical Kidney Journal|November 12, 2025
Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL studyDavid C Wheeler, Kevin M Pantalone, Lixin Guo, et al.
The Lancet. Diabetes & Endocrinology|October 16, 2020
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trialMegumi Oshima, Brendon L Neuen, Meg J Jardine, et al.
Journal of Molecular Biology|February 2, 2010
De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteinsLei Shi, John C Wheeler, Raymond W Sweet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 2022
Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysisPhil McEwan, Rebecca Boyce, Juan Jose Garcia Sanchez, et al.
The Lancet. Diabetes & Endocrinology|October 7, 2021
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trialNiels Jongs, Tom Greene, Glenn M Chertow, et al.
Scientific Reports|May 11, 2017
Synthetic ferrimagnet nanowires with very low critical current density for coupled domain wall motionSerban Lepadatu, Henri Saarikoski, Robert Beacham, et al.
Pageof 122

Showing results (931-940 of 1,217) with videos related to

Sort By:
Pageof 122
Annals of Internal Medicine|December 5, 2022
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKDMeir Schechter, Niels Jongs, Glenn M Chertow, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 1, 2023
Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of FrailtyPriya Vart, Jawad H Butt, Niels Jongs, et al.
Journal of Neurodevelopmental Disorders|August 7, 2014
Associated features in females with an FMR1 premutationAnne C Wheeler, Donald B Bailey, Elizabeth Berry-Kravis, et al.
Kidney International|February 5, 2015
Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conferenceMarkus Ketteler, Grahame J Elder, Pieter Evenepoel, et al.
Clinical Kidney Journal|November 12, 2025
Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL studyDavid C Wheeler, Kevin M Pantalone, Lixin Guo, et al.
The Lancet. Diabetes & Endocrinology|October 16, 2020
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trialMegumi Oshima, Brendon L Neuen, Meg J Jardine, et al.
Journal of Molecular Biology|February 2, 2010
De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteinsLei Shi, John C Wheeler, Raymond W Sweet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 2022
Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysisPhil McEwan, Rebecca Boyce, Juan Jose Garcia Sanchez, et al.
The Lancet. Diabetes & Endocrinology|October 7, 2021
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trialNiels Jongs, Tom Greene, Glenn M Chertow, et al.
Scientific Reports|May 11, 2017
Synthetic ferrimagnet nanowires with very low critical current density for coupled domain wall motionSerban Lepadatu, Henri Saarikoski, Robert Beacham, et al.
Pageof 122